← Open Payments lookup

PAULA STULTZ: Open Payments

NPI 1164569737 · BROWNWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,125 in 63 payments from 17 companies in 2025. Trend: 2023 $533 · 2024 $1,218 · 2025 $1,125

Food & beverage: $1,035Education: $90
CompanyPaymentsAmount
Janssen Biotech, Inc.12$249
ABBVIE INC.13$199
Takeda Pharmaceuticals U.S.A., Inc.10$159
Celltrion USA Inc.5$90
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$81
Ipsen Biopharmaceuticals, Inc2$51
Phathom Pharmaceuticals, Inc.3$44
Ardelyx, Inc.2$38
Madrigal Pharmaceuticals2$37
Regeneron Healthcare Solutions, Inc.2$36

Products named: TREMFYA, ENTYVIO, VEGZELMA, XIFAXAN, RINVOQ, EOHILIA, SKYRIZI, IQIRVO.

Industry payments across TX — which companies pay providers there.